Apollon Wealth Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.14M Sell
94,315
-39,574
-30% -$3.29M 0.09% 186
2026
Q2
$9.02M Buy
133,889
+112,469
+525% +$7.49M 0.11% 171
2026
Q1
$1.35M Buy
21,420
+5,099
+31% +$355K 0.02% 490
2025
Q4
$1.08M Sell
16,321
-3,703
-18% -$239K 0.02% 546
2025
Q3
$1.35M Sell
20,024
-1,172
-6% -$92.7K 0.02% 478
2025
Q2
$1.85M Buy
21,196
+1,526
+8% +$120K 0.04% 375
2025
Q1
$1.34M Buy
19,670
+1,967
+11% +$161K 0.03% 423
2024
Q4
$1.38M Sell
17,703
-702
-4% -$52K 0.03% 417
2024
Q3
$1.23M Sell
18,405
-3,738
-17% -$307K 0.03% 419
2024
Q2
$2.51M Buy
22,143
+163
+0.7% +$20.6K 0.08% 235
2024
Q1
$3.05M Buy
21,980
+6
+0% +$754 0.1% 195
2023
Q4
$2.73M Sell
21,974
-696
-3% -$71.1K 0.09% 198
2023
Q3
$2.12M Buy
22,670
+1,092
+5% +$123K 0.11% 179
2023
Q2
$2.77M Sell
21,578
-2,456
-10% -$297K 0.13% 162
2023
Q1
$2.79M Sell
24,034
-653
-3% -$73.1K 0.17% 125
2022
Q4
$2.8M Sell
24,687
-583
-2% -$64K 0.2% 109
2022
Q3
$2.04M Buy
25,270
+1,413
+6% +$120K 0.17% 129
2022
Q2
$1.78M Sell
23,857
-111
-0.5% -$10.1K 0.15% 151
2022
Q1
$3.07M Buy
23,968
+14,036
+141% +$1.54M 0.22% 97
2021
Q4
$268K Buy
+9,932
New +$1.43M 0.02% 609
2020
Q3
– Sell
-220
Closed -$22K – 296
2020
Q2
$22K Buy
+220
New +$19.7K 0.01% 356

Other funds holding DXCM

Apollon Wealth Management's DXCM Position: Q3 2026 in Review

Apollon Wealth Management reduced its DexCom (DXCM) stake by 30% in Q3 2026, selling an estimated $3.29M and leaving 94,315 shares worth $8.14M. The position accounts for 0.09% of the portfolio, ranked #186.

Apollon Wealth Management first reported a position in DXCM in Q2 2020 and has held it in 21 quarters since. The position peaked at $9.02M in Q2 2026. 620 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Apollon Wealth Management held 94,315 shares of DexCom worth $8.14M as of Q3 2026.
  • Apollon Wealth Management sold 39,574 DexCom shares in Q3 2026, an estimated $3.29M.
  • DexCom made up 0.09% of Apollon Wealth Management's portfolio in Q3 2026, its #186 holding.
  • Apollon Wealth Management first reported a position in DexCom in Q2 2020 and has held it in 21 quarters since.
  • Apollon Wealth Management's DexCom position peaked at $9.02M in Q2 2026.
  • 620 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Apollon Wealth Management's 13F filing for Q3 2026, filed 23 Oct 2026.